Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05921552 · ClinicalTrials.gov registry record · NA

Senior Adult Hepatobiliary Prehab Study

A NA study of Cholangiocarcinoma and Liver Metastases, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Active
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT05921552: Active NA study of Cholangiocarcinoma and Liver Metastases, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

NCT05921552 is a NA study of Cholangiocarcinoma and Liver Metastases that is active but no longer recruiting, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 25 participants, below the 385-participant average among 60 other Cholangiocarcinoma trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05921552, a NA study of Cholangiocarcinoma and Liver Metastases, is active but no longer recruiting, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to evaluate an exercise program for individuals with hepatobiliary cancer planning for surgery.

Primary Outcome

Enrollment will be considered feasible if ≥60% of eligible and approached patients actually consent and enroll

Conditions Studied

Cholangiocarcinoma Liver Metastases Hepatobiliary Cancer

Interventions

  • BEHAVIORAL Resistance Training
  • BEHAVIORAL Aerobic Training

Study Locations (1)

Florida

  • Moffitt Cancer Center - Tampa

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2023-06-26
Est. Completion 2026-11-19
Phase NA
H. Lee Moffitt Cancer Center and Research Institute

502 total trials

What the registry record for NCT05921552 still lists

NCT05921552 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 385-participant average among 60 other Cholangiocarcinoma trials with a reported enrollment target (94% lower).

The record links to 3 conditions, with Cholangiocarcinoma appearing as the primary indexed condition, and to 2 interventions - of which Resistance Training is the first listed.

NCT05921552 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT05921552 about?

NCT05921552 is a clinical study titled "Senior Adult Hepatobiliary Prehab Study". The purpose of the study is to evaluate an exercise program for individuals with hepatobiliary cancer planning for surgery.

What is the current status of trial NCT05921552?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2023-06-26. Estimated completion is 2026-11-19.

What conditions does trial NCT05921552 study?

This clinical trial studies the following conditions: Cholangiocarcinoma, Liver Metastases, Hepatobiliary Cancer.

What interventions are being tested in trial NCT05921552?

The interventions under investigation include: Resistance Training (BEHAVIORAL), Aerobic Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT05921552?

This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05921552 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cholangiocarcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05921552's enrollment target sits among peer trials

25 55th of 60 higher than 6 of 60 other Cholangiocarcinoma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cholangiocarcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT05921552, the US trial registry maintained by the National Library of Medicine. NCT05921552 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.